Loading...
Erythromycin-resistant strains of Propionibacterium acnes, first described in the late 1970s, appear to be becoming a significant clinical problem. Researchers in Britain previously reported that 25% of patients at their large acne center have erythromycin-resistant P. acnes on their skin, and they recently showed that patients with predominantly resistant P. acnes fail to respond to oral erythromycin therapy. In an effort to ensure the continued efficacy of erythromycin in acne therapy, these researchers investigated whether benzoyl peroxide, a broad-spectrum antibacterial agent, adds to the antibacterial effect of erythromycin.
Benzoyl peroxide was tested alone and in combination with erythromycin against 40 erythromycin-sensitive and -res…